BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt-Montoya S, Black SA, Ten Cate-Hoek AJ, Elalamy I, Enzmann FK, Geroulakos G, Gottsäter A, Hunt BJ, Mansilha A, Nicolaides AN, Sandset PM, Stansby G, Esvs Guidelines Committee, de Borst GJ, Bastos Gonçalves F, Chakfé N, Hinchliffe R, Kolh P, Koncar I, Lindholt JS, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, De Maeseneer MG, Comerota AJ, Gloviczki P, Kruip MJHA, Monreal M, Prandoni P, Vega de Ceniga M. Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg 2021;61:9-82. [PMID: 33334670 DOI: 10.1016/j.ejvs.2020.09.023] [Cited by in Crossref: 116] [Cited by in F6Publishing: 126] [Article Influence: 38.7] [Reference Citation Analysis]
Number Citing Articles
1 Sun P, Wu H, Bai X, Zhang L, Zhang C, Wang X, Lou C, Li B, Li Z, Bai H. Decellularized fish swim bladder patch loaded with mesenchymal stem cells inhibits neointimal hyperplasia. J Biomed Mater Res B Appl Biomater 2023;111:551-9. [PMID: 36200602 DOI: 10.1002/jbm.b.35172] [Reference Citation Analysis]
2 Zaccone V, Santoro L, Guerrieri E, Diblasi I, Roncarati I, Viticchi G, Vecchiarelli P, Santoliquido A, Fiore F, Molfino A, Landi F, Moroncini G, Gasbarrini A, Muscaritoli M, Falsetti L. Prevention and treatment of catheter-related venous thrombosis in long-term parenteral nutrition: A SINuC position statement. Front Nutr 2023;10. [DOI: 10.3389/fnut.2023.1106327] [Reference Citation Analysis]
3 Zhang C, Wang X, Cardiovascular Group, Geriatrics Branch of Chinese Medical Association. Chinese expert consensus on antithrombotic management of high‐risk elderly patients with chronic coronary syndrome. Aging Medicine 2023. [DOI: 10.1002/agm2.12234] [Reference Citation Analysis]
4 Vedantham S, Desai KR, Weinberg I, Marston W, Winokur R, Patel S, Kolli KP, Azene E, Nelson K. Society of Interventional Radiology Position Statement on the Endovascular Management of Acute Iliofemoral Deep Vein Thrombosis. J Vasc Interv Radiol 2023;34:284-299.e7. [PMID: 36375763 DOI: 10.1016/j.jvir.2022.10.038] [Reference Citation Analysis]
5 Slater LT, Williams JA, Schofield PN, Russell S, Pendleton SC, Karwath A, Fanning H, Ball S, Hoehndorf R, Gkoutos GV. Klarigi: Characteristic explanations for semantic biomedical data. Comput Biol Med 2023;153:106425. [PMID: 36638616 DOI: 10.1016/j.compbiomed.2022.106425] [Reference Citation Analysis]
6 Li JY, Liu JL, Tian X, Jia W, Jiang P, Cheng ZY, Zhang YX, Liu X, Zhou M. Clinical outcomes of AngioJet pharmacomechanical thrombectomy versus catheter-directed thrombolysis for the treatment of filter-related caval thrombosis. World J Clin Cases 2023; 11(3): 598-609 [DOI: 10.12998/wjcc.v11.i3.598] [Reference Citation Analysis]
7 Varlas VN, Borș RG, Plotogea M, Iordache M, Mehedințu C, Cîrstoiu MM. Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue. IJERPH 2023;20:1949. [DOI: 10.3390/ijerph20031949] [Reference Citation Analysis]
8 Zhang X, Huang X, Li G, Gu C, Sun Y. Single-Stage Endovascular Thrombectomy and Stenting as the First-Line Strategy in the Treatment of Phlegmasia Cerulea Dolens Caused by Iliac Vein Lesions. Ann Vasc Surg 2023:S0890-5096(23)00015-8. [PMID: 36681270 DOI: 10.1016/j.avsg.2023.01.003] [Reference Citation Analysis]
9 Kaperiz KA, Rastatueva AO, Yavelov IS, Drapkina OM. Comparison of endovenous laser ablation and conservative treatment in acute thrombophlebitis of the varicose great saphenous vein: rationale, design and first results of clinical trial. Cardiovasc Ther Prev 2023;21:3461. [DOI: 10.15829/1728-8800-2022-3461] [Reference Citation Analysis]
10 de Kleijn RJCMF, Schropp L, Westerink J, van Hattum ES, Petri BJ, de Borst GJ. Functional outcome of arterial thoracic outlet syndrome treatment. Front Surg 2022;9:1072536. [PMID: 36726955 DOI: 10.3389/fsurg.2022.1072536] [Reference Citation Analysis]
11 Andriyashkin AV, Loban KM, Kalinina AA, Ivakhov GB, Zolotukhin IA, Sazhin AV. Risk factors of venous thromboembolism after incisional ventral hernia repair: author's reply. Hernia 2023. [PMID: 36640196 DOI: 10.1007/s10029-023-02736-9] [Reference Citation Analysis]
12 Yavelov IS. Safety of discontinuation of anticoagulants after venous thromboembolism: whether D-dimer level should be taken into account? Aterotromboz 2023;12:22-31. [DOI: 10.21518/2307-1109-2022-12-2] [Reference Citation Analysis]
13 Gong M, Fu G, Liu Z, Zhao B, Kong J, He X, Gu J. Angiojet pharmacomechanical thrombectomy versus anticoagulant therapy alone in massive cancer-associated thrombosis: a single centre retrospective cohort study. J Thromb Thrombolysis 2023. [PMID: 36630028 DOI: 10.1007/s11239-023-02770-5] [Reference Citation Analysis]
14 Gong M, Kong J, Shi Y, Zhao B, Liu Z, He X, Gu J. Risk factors and a predictive model for nonfilter-associated inferior vena cava thrombosis in patients with lower extremity deep vein thrombosis. Front Cardiovasc Med 2022;9:1083152. [PMID: 36712257 DOI: 10.3389/fcvm.2022.1083152] [Reference Citation Analysis]
15 Schropp L, de Kleijn RJCMF, Westerink J, Nijkeuter M, Vonken EJ, van der Schaaf IC, Goedee HS, Vrancken AFJE, van Hattum ES, Petri BJ, de Borst GJ; TROTS registry collaborators. Thoracic outlet syndrome (TROTS) registry: A study protocol for the primary upper extremity deep venous thrombosis section. PLoS One 2023;18:e0279708. [PMID: 36608058 DOI: 10.1371/journal.pone.0279708] [Reference Citation Analysis]
16 Björck M, Boyle JR. EJVES 2023: Continuity, Renewal and Teambuilding. Eur J Vasc Endovasc Surg 2023;65:1-2. [PMID: 36396103 DOI: 10.1016/j.ejvs.2022.11.001] [Reference Citation Analysis]
17 Bauersachs RM. Fondaparinux Sodium: Recent Advances in the Management of Thrombosis. J Cardiovasc Pharmacol Ther 2023;28:10742484221145010. [PMID: 36594404 DOI: 10.1177/10742484221145010] [Reference Citation Analysis]
18 Muenkhoff AJ, Clemens RK, Vanetta C, Staub D, Hasselmann DG. Duration of post-sclerotherapy hyperpigmentation in patients with and without anticoagulation. Vasa 2023;52:71-3. [PMID: 36617970 DOI: 10.1024/0301-1526/a001045] [Reference Citation Analysis]
19 Alshaya OA, Korayem GB, Al Yami MS, Qudayr AH, Althewaibi S, Fetyani L, Alshehri S, Alnashmi F, Albasseet M, Alshehri L, Alhushan LM, Almohammed OA. Comparative Effectiveness of Apixaban and Rivaroxaban Lead-in Dosing in VTE Treatment: Observational Multicenter Real-World Study. J Clin Med 2022;12. [PMID: 36615002 DOI: 10.3390/jcm12010199] [Reference Citation Analysis]
20 Wu Z, Li Y, Lei J, Qiu P, Liu H, Yang X, Chen T, Lu X. Developing and optimizing a machine learning predictive model for post-thrombotic syndrome in a longitudinal cohort of patients with proximal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord 2022:S2213-333X(22)00505-4. [PMID: 36580997 DOI: 10.1016/j.jvsv.2022.12.006] [Reference Citation Analysis]
21 de Kleijn RJCMF, Schropp L, Westerink J, Nijkeuter M, van Laanen J, Teijink J, Ünlu C, Vos AWF, van Hattum ES, Petri BJ, de Borst GJ. Current treatment strategies for primary upper extremity deep venous thrombosis; a retrospective observational multicenter case series. Front Surg 2022;9:1080584. [PMID: 36620382 DOI: 10.3389/fsurg.2022.1080584] [Reference Citation Analysis]
22 Shi Y, Yuan Y, Gong M, Su H, Chen L, Huang H, Lu Z, Zhou Y, Gu J. The association between iliac vein compression degree and characteristics of first diagnosed left lower extremity deep vein thrombosis. Front Cardiovasc Med 2022;9:1073586. [PMID: 36620613 DOI: 10.3389/fcvm.2022.1073586] [Reference Citation Analysis]
23 Juenger J, Mahlmann A, Udelnow A, Bauersachs R, Braun-dullaeus RC, Herold J. The Role of Anticoagulants and Platelet Aggregation Inhibitors in the Treatment of Pseudoaneurysms and Risk of Venous Thrombosis. Angiology 2022. [DOI: 10.1177/00033197221143321] [Reference Citation Analysis]
24 Andriyashkin AV, Loban KM, Kalinina AA, Ivakhov GB, Zolotukhin IA, Sazhin AV. Risk factors of venous thromboembolism after incisional ventral hernia repair. Hernia 2022. [DOI: 10.1007/s10029-022-02726-3] [Reference Citation Analysis]
25 Karathanos C, Kakkos SK, Georgiadis G, Ioannou C, Vasdekis S, Chatzis D, Latzios P, Giannoukas AD; SeVEN Collaborators. Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin. Phlebology 2022;:2683555221143576. [PMID: 36461172 DOI: 10.1177/02683555221143576] [Reference Citation Analysis]
26 Rumba R, Krievins D, Savlovskis J, Ezite N, Kukulis I, Petrosina E, Mouttet L, Lacis A, Zarins CK. Long term clinical and functional venous outcomes after endovascular transvenous femoro-popliteal bypass. Int Angiol 2022;41:509-16. [PMID: 36194385 DOI: 10.23736/S0392-9590.22.04937-9] [Reference Citation Analysis]
27 Bauersachs R. Antikoagulation bei Thrombose und Lungenembolie. Aktuelle Kardiologie 2022;11:543-550. [DOI: 10.1055/a-1952-2377] [Reference Citation Analysis]
28 ten Cate-hoek AJ. Lower strength stockings: is less better? The Lancet Haematology 2022;9:e865-e866. [DOI: 10.1016/s2352-3026(22)00266-6] [Reference Citation Analysis]
29 Gavrilov S, Mishakina N, Grishenkova A. Venous thromboembolism after interventions on the ovarian veins in patients with pelvic venous disorder. Annals of Vascular Surgery 2022. [DOI: 10.1016/j.avsg.2022.11.016] [Reference Citation Analysis]
30 Amaral FC, Baptista-Silva JC, Nakano LC, Flumignan RL. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery. Cochrane Database Syst Rev 2022;11:CD013683. [PMID: 36413425 DOI: 10.1002/14651858.CD013683.pub2] [Reference Citation Analysis]
31 Lindhoff-last E, Birschmann I, Bidenharn AJ, Kuhn J, Lindau S, Konstantinides S, Grottke O, Nowak-göttl U, Lucks J, Zydek B, von Heymann C, Sümnig A, Beyer-westendorf J, Schellong S, Meybohm P, Greinacher A, Herrmann E. Pharmacokinetics of Phenprocoumon in Emergency Situations–Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry). Pharmaceuticals 2022;15:1437. [DOI: 10.3390/ph15111437] [Reference Citation Analysis]
32 Lobastov KV, Shaldina MV, Borsuk DA, Schastlivtsev IV, Laberko LA, Fokin АA. Current state of the problem of risk assessment and prevention of venous thromboembolic complications after thermal obliteration of superficial veins. Ambulatornaya khirurgiya 2022;19:62-71. [DOI: 10.21518/1995-1477-2022-19-2-62-71] [Reference Citation Analysis]
33 Noumegni SR, Tromeur C, Hoffmann C, Mao RL, Moigne EL, Moreuil C, Mansourati V, Nasr B, Gentric JC, Guegan M, Poulhazan E, Bressollette L, Lacut K, Didier R, Couturaud F. Predictors of Recurrent Venous Thromboembolism or Arterial Thrombotic Events during and after Anticoagulation for a First Venous Thromboembolism. Semin Thromb Hemost 2022. [PMID: 36252603 DOI: 10.1055/s-0042-1757899] [Reference Citation Analysis]
34 Turner BRH, Thapar A, Jasionowska S, Javed A, Machin M, Lawton R, Gwozdz AM, Davies AH. Systematic Review and Meta-Analysis of the Pooled Rate of Post-Thrombotic Syndrome After Isolated Distal Deep Venous Thrombosis. Eur J Vasc Endovasc Surg 2022:S1078-5884(22)00621-9. [PMID: 36257568 DOI: 10.1016/j.ejvs.2022.10.018] [Reference Citation Analysis]
35 Liu X, Peng X, Rong C, Zhang W. Acute pulmonary embolism following corticosteroid administration in acute severe ulcerative colitis with gastrointestinal bleeding: A case report. Front Cardiovasc Med 2022;9:1018462. [PMID: 36304550 DOI: 10.3389/fcvm.2022.1018462] [Reference Citation Analysis]
36 Bredikhin RA, Akhmetzyanov RV, Khayrullin RN. Expanding the possibilities of treatment and prevention of venous thromboembolic complications in cancer patients. The role of oral anticoagulants. Klinicist 2022;16:17-26. [DOI: 10.17650/1818-8338-2022-16-2-k667] [Reference Citation Analysis]
37 Shi Y, Wang T, Yuan Y, Su H, Chen L, Huang H, Lu Z, Gu J. Silent Pulmonary Embolism in Deep Vein Thrombosis: Relationship and Risk Factors. Clin Appl Thromb Hemost 2022;28:10760296221131034. [PMID: 36199255 DOI: 10.1177/10760296221131034] [Reference Citation Analysis]
38 Khrebtiy YV, Tsyhalko DV, Melnychuk MO. Treatment of Bilateral Venous Thrombosis in a Patient with Aplasia of the Inferior Vena Cava. ujcvs 2022;30:109-114. [DOI: 10.30702/ujcvs/22.30(03)/kht036-109114] [Reference Citation Analysis]
39 Duran M, Garabet W, Grabitz K, Schelzig H, Simon F. Therapie der venösen Thrombose der unteren Extremität mit den Schwerpunkten Schwangerschaft und Puerperium. Gefässchirurgie 2022. [DOI: 10.1007/s00772-022-00929-7] [Reference Citation Analysis]
40 Wang B, Jiang C, Zhang Y, Li X, Xu H. Outcome of anticoagulation with rivaroxaban in patients with non-retrieved inferior vena cava filters for the prevention of filter thrombosis: a retrospective cohort study. BMC Cardiovasc Disord 2022;22. [DOI: 10.1186/s12872-022-02849-6] [Reference Citation Analysis]
41 Hoexum F, Jongkind V, Coveliers HME, Wisselink W, Yeung KK. Long-Term Outcomes of Nonoperative and Surgical Management of Paget-Schroetter Syndrome. J Endovasc Ther 2022;:15266028221120360. [PMID: 36082395 DOI: 10.1177/15266028221120360] [Reference Citation Analysis]
42 Frey V, Sebastian T, Barco S, Spirk D, Hayoz D, Périard D, Kucher N, Betticher D, Engelberger RP. Impact of concomitant popliteal vein thrombosis in patients with acute iliofemoral deep vein thrombosis treated with endovascular early thrombus removal. Vasa 2022;51:282-290. [DOI: 10.1024/0301-1526/a001017] [Reference Citation Analysis]
43 Gombert A, Heinzel A, Barbati ME, Doukas P, Schmitt L, Shekarchian S, Winz O, Mottaghy F, Jalaie H. Assessment of the lymphatic system by indirect lymphography in patients with post-thrombotic syndrome. J Vasc Surg Venous Lymphat Disord 2022;10:1072-1078.e1. [PMID: 35561971 DOI: 10.1016/j.jvsv.2022.03.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Wang X, Chen X, Gao X, Feng H. Iliac vein compression syndrome caused by a large bladder diverticulum: Case report and literature review. J Int Med Res 2022;50:3000605221123670. [PMID: 36124896 DOI: 10.1177/03000605221123670] [Reference Citation Analysis]
45 Åström H, Blomgren L. Does eradication of superficial vein incompetence after superficial vein thrombosis reduce the risk of recurrence and of deep vein thrombosis? A pilot study evaluating clinical practice in Örebro county, Sweden. Phlebology 2022;37:610-615. [DOI: 10.1177/02683555221113402] [Reference Citation Analysis]
46 Aleidan FAS, Almanea RK, Almoneef AT, Shalash NA, Alrajhi NA, Almousa SF, Al Raizah A, Abuelgasim KA. Incidence and Predictors of Recurrence and Mortality Following First Venous Thromboembolism Among the Saudi Population: Single-Center Cohort Study. IJGM 2022;Volume 15:7559-7568. [DOI: 10.2147/ijgm.s359893] [Reference Citation Analysis]
47 Weissler EH, Cox MW, Commander SJ, Williams ZF. Restoring venous patency with the ClotTriever following deep vein thrombosis. Ann Vasc Surg 2022:S0890-5096(22)00500-3. [PMID: 36007777 DOI: 10.1016/j.avsg.2022.07.031] [Reference Citation Analysis]
48 Schlager O, Wolf F, Mueller M, Gschwandtner ME, Loewe C, Koppensteiner R, Beitzke D, Willfort-Ehringer A. Closure of Post-thrombotic Iliac Arteriovenous Fistulas by Iliac Vein Recanalization. J Endovasc Ther 2022;:15266028221113745. [PMID: 35980088 DOI: 10.1177/15266028221113745] [Reference Citation Analysis]
49 Chen Y, Tang B, Nie M, Qi X, Wang F, Wang H. The Incidence, Risk Factors, Characteristics and Prognosis of Recurrent Deep Venous Thrombosis in the Contralateral Lower Extremity. J Vasc Surg Venous Lymphat Disord 2022:S2213-333X(22)00344-4. [PMID: 35961631 DOI: 10.1016/j.jvsv.2022.07.004] [Reference Citation Analysis]
50 Zhang K, Yan J, Tang M. Effects of CDT on Hemodynamics and Quality of Life in a Subgroup of Patients with Lower Limb Deep Vein Thrombosis Carel: A Case-Control Study. Computational and Mathematical Methods in Medicine 2022;2022:1-10. [DOI: 10.1155/2022/6607240] [Reference Citation Analysis]
51 Dick F, Björck M, Gargiulo M. EJVES Facing a Number of Challenges, but Well Prepared for the Future - Just Like the ESVS! Eur J Vasc Endovasc Surg 2022;64:147-9. [PMID: 36309460 DOI: 10.1016/j.ejvs.2022.09.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Flumignan CD, Nakano LC, Baptista-silva JC, Flumignan RL. Antiplatelet agents for the treatment of deep venous thrombosis. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd012369.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Timerbulatov MV, Murasov TM, Murasov AM. Surgical Specifics of Lower Limb Superficial Thrombophlebitis Combined with Undifferentiated Connective Tissue Disease. Kreativnaâ hirurgiâ i onkologiâ 2022;12:112-117. [DOI: 10.24060/2076-3093-2022-12-2-112-117] [Reference Citation Analysis]
54 Alexiou VG, Ntanika A, Pappas G, Vassiliou A, Palialexis K, Geroulakos G. Conservative treatment vs thrombus removal for Iliofemoral vein thrombosis in patients with congenital abnormalities of the inferior vena cava: a case report and systematic review of the literature. J Thromb Thrombolysis 2022. [PMID: 35829838 DOI: 10.1007/s11239-022-02674-w] [Reference Citation Analysis]
55 Black S, Choudhury E. Venous thrombosis. Surgery (Oxford) 2022;40:401-410. [DOI: 10.1016/j.mpsur.2022.05.009] [Reference Citation Analysis]
56 Paik J. Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism. Paediatr Drugs 2022;24:423-31. [PMID: 35699915 DOI: 10.1007/s40272-022-00516-z] [Reference Citation Analysis]
57 Balakhonova TV, Ershova AI, Ezhov MV, Barbarash OL, Bershtein LL, Bogachev VY, Voevoda MI, Genkel VV, Gurevich VS, Duplyakov DV, Imaev TE, Konovalov GA, Kosmacheva ED, Lobastov KV, Mitkova MD, Nikiforov VS, Rotar OP, Suchkov IA, Yavelov IS, Mitkov VV, Akchurin RS, Drapkina OM, Boytsov SA. Focused vascular ultrasound. Consensus of Russian experts. Cardiovasc Ther Prev 2022;21:3333. [DOI: 10.15829/1728-8800-2022-3333] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 de Ávila RB, Marcondes GB, Dias SVM, da Silveira BP, de Amorim JE, Neto HJG, Nakano LCU, Flumignan RLG. External validation of Villalta score in high-middle income country patients with deep vein thrombosis. Medicine (Baltimore) 2022;101:e29367. [PMID: 35713439 DOI: 10.1097/MD.0000000000029367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Yang M, Chen L, Zhang M, Huang X, Zhao W, Wang H. Evidence-Based Nursing Model in Interventional Thrombolysis for Acute Lower Extremity Arterial Embolism. Contrast Media Mol Imaging 2022;2022:4488797. [PMID: 35677027 DOI: 10.1155/2022/4488797] [Reference Citation Analysis]
60 Matyushkin AV. [Features of the course and therapeutic aspects of deep vein thrombosis in elderly and senile patients]. Khirurgiia (Mosk) 2022;:133-9. [PMID: 35658145 DOI: 10.17116/hirurgia2022061133] [Reference Citation Analysis]
61 Noumegni SR, Le Mao R, de Moreuil C, Hoffmann C, Le Moigne E, Tromeur C, Mansourati V, Nasr B, Gentric J, Guegan M, Poulhazan E, Bressollette L, Lacut K, Didier R, Couturaud F. Anticoagulation for VTE. Chest 2022. [DOI: 10.1016/j.chest.2022.05.038] [Reference Citation Analysis]
62 Ferri N, Colombo E, Tenconi M, Baldessin L, Corsini A. Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice. Pharmaceutics 2022;14:1120. [DOI: 10.3390/pharmaceutics14061120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
63 Prandoni P, Bilora F, Pesavento R, Salgueiro G, Blanco-molina A, Lòpez-reyes R, Monreal M, Riete Investigators AT. Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry. Bleed Thromb Vascul Biol 2022;1. [DOI: 10.4081/btvb.2022.28] [Reference Citation Analysis]
64 Badesha AS, Khan T, Abdellatif E. Iliac vein deep vein thrombosis as an atypical presentation of an adrenocortical carcinoma. BMJ Case Rep 2022;15:e248708. [PMID: 35580936 DOI: 10.1136/bcr-2021-248708] [Reference Citation Analysis]
65 Shaydakov ME, Ting W, Sadek M, Aziz F, Diaz JA, Comerota AJ, Lurie F, Blebea J, Eklöf BG, Lugli M, De Maeseneer MGR, Kakkos SK, Nicolaides A, Heim D, Welch HJ; American Venous Forum Research Committee. Extended Anticoagulation for Venous Thromboembolism: A Survey of the American Venous Forum and the European Venous Forum. J Vasc Surg Venous Lymphat Disord 2022:S2213-333X(22)00192-5. [PMID: 35561974 DOI: 10.1016/j.jvsv.2022.03.013] [Reference Citation Analysis]
66 Bauersachs R. Beinvenenthrombose und Lungenembolie: Diagnostik und Therapie. Internist. [DOI: 10.1007/s00108-022-01349-1] [Reference Citation Analysis]
67 Khanna AK, Khanna D. Venous Thromboembolism and COVID-19-an Epidemiological Perspective. Indian J Surg 2022;:1-8. [PMID: 35529246 DOI: 10.1007/s12262-022-03423-2] [Reference Citation Analysis]
68 Stücker M. [Superficial venous thrombosis, varicose veins, and chronic venous insufficiency: an update for clinical practice]. Internist (Berl) 2022. [PMID: 35503127 DOI: 10.1007/s00108-022-01341-9] [Reference Citation Analysis]
69 Lanthier L, Letemplier G, Plourde M, Cauchon M. BaladoCritique : chez les sujets ambulatoires avec thrombophlébite profonde du membre inférieur soupçonnée, une nouvelle stratégie diagnostique utilisant les D-Dimères ajustés en fonction de la probabilité clinique permet-elle d’exclure de façon sécuritaire ce diagnostic tout en diminuant le recours à l’imagerie ? La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2022.03.344] [Reference Citation Analysis]
70 Casian D, Bzovii F, Culiuc V, Gutu E. Urgent surgery versus anticoagulation for treatment of superficial vein thrombosis in patients with varicose veins. Vasa 2022;51:174-181. [DOI: 10.1024/0301-1526/a001000] [Reference Citation Analysis]
71 Mcintyre A, Sadowsky C, Behrman A, Martin R, Augutis M, Cassidy C, Betz R, Ertzgaard P, Mulcahey M; the SCIRE Project Research Group. A Systematic Review of the Scientific Literature for Rehabilitation/Habilitation Among Individuals With Pediatric-Onset Spinal Cord Injury. Topics in Spinal Cord Injury Rehabilitation 2022;28:13-90. [DOI: 10.46292/sci21-00046] [Reference Citation Analysis]
72 Santos BC, Flumignan RL, Civile VT, Atallah ÁN, Nakano LC; Cochrane Vascular Group. Prophylactic anticoagulants for non-hospitalised people with COVID-19. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd015102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Müller L, Mendoza E, Stücker M. Is there an increased incidence of subclinical proximal deep vein thrombosis after mild to moderate course of SARS-CoV-2 infection? Eur Heart J 2022:ehac162. [PMID: 35383377 DOI: 10.1093/eurheartj/ehac162] [Reference Citation Analysis]
74 Behrendt CA, Twerenbold R, Blankenberg S. The everlasting challenge to identify deep vein thrombosis in both clinical practice and research. Eur Heart J 2022:ehac164. [PMID: 35383353 DOI: 10.1093/eurheartj/ehac164] [Reference Citation Analysis]
75 Omar Mohamed Ozaal A, Fernando T. Deep vein thrombosis in an elderly patient with chronic limb-threatening ischaemia presented with limb swelling: The role of diagnostic tools and surgical dilemma. SAGE Open Medical Case Reports 2022;10:2050313X2210891. [DOI: 10.1177/2050313x221089121] [Reference Citation Analysis]
76 Noumegni SR, Didier R, Mansourati V, Tromeur C, Le Moigne E, Hoffmann C, Nasr B, Gentric J, Guegan M, Poulhazan E, Lacut K, Bressollette L, Le Mao R, Couturaud F. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.04.016] [Reference Citation Analysis]
77 De Maeseneer M. New clinical practice guidelines on the management of chronic venous disease – towards new horizons. JMV-Journal de Médecine Vasculaire 2022;47:51-52. [DOI: 10.1016/j.jdmv.2022.04.006] [Reference Citation Analysis]
78 Zhang J, Ma F, Yao J, Hao B, Xu H, Guo X, Gao H, Yang T. Development and validation of a clinical prediction model for post thrombotic syndrome following anticoagulant therapy for acute deep venous thrombosis. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.04.003] [Reference Citation Analysis]
79 Galyfos G, Liakopoulos D, Sigala F, Filis K. New paradigms in minimally-invasive vascular surgery. Expert Rev Cardiovasc Ther 2022. [PMID: 35341434 DOI: 10.1080/14779072.2022.2058492] [Reference Citation Analysis]
80 Georgiadis GS, Argyriou C, Tottas S, Foutzitzi S, Drosos G. Extensive Inferior Vena Cava Thrombosis Related to COVID-19 Infection in a Patient with Retrievable Filter Due to Multiple Pelvic Bone Fractures. Vasc Specialist Int 2022;38:4. [PMID: 35322795 DOI: 10.5758/vsi.210070] [Reference Citation Analysis]
81 ICM-VTE General Delegates. Recommendations from the ICM-VTE: General. J Bone Joint Surg Am 2022;104:4-162. [PMID: 35315607 DOI: 10.2106/JBJS.21.01531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
82 Schropp L, de Kleijn RJCMF, Vonken EJ, van Laanen J, Teijink J, Ünlu Ç, Vos FAW, van Hattum ES, Petri BJ, de Borst GJ. Multicenter Case Series and Literature Review on Durability of Stents in the Thoracic Outlet. J Endovasc Ther 2022;:15266028221081078. [PMID: 35255758 DOI: 10.1177/15266028221081078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
83 Schwein A, Magnus L, Markovits J, Chinnadurai P, Autry K, Jenkins L, Barnes R, Vekilov DP, Shah D, Chakfé N, Bismuth J. Endovascular Porcine Model of Iliocaval Venous Thrombosis. Eur J Vasc Endovasc Surg 2022:S1078-5884(21)00975-8. [PMID: 35272950 DOI: 10.1016/j.ejvs.2021.12.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Ockert S. Rekanalisierende Therapie der akuten tiefen Becken-Bein-Venenthrombose. Gefässchirurgie 2022;27:117-124. [DOI: 10.1007/s00772-022-00870-9] [Reference Citation Analysis]
85 Schafer K, Goldschmidt E, Oostra D, Kaminski B, Mattin M, Lurie F. Defining the Role of Risk Stratification and Duplex Ultrasound in the Diagnosis of Acute Lower Extremity Deep Vein Thrombosis. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2022. [DOI: 10.1016/j.jvsv.2022.02.017] [Reference Citation Analysis]
86 Özhan A, Bastopcu M. Factors Associated with Positive Thrombus Findings at Ultrasonography in Covid-19 Ward Patients who Underwent Imaging for Suspected DVT Under Prophylactic Anticoagulation. J Vasc Surg Venous Lymphat Disord 2022:S2213-333X(22)00093-2. [PMID: 35218956 DOI: 10.1016/j.jvsv.2022.02.012] [Reference Citation Analysis]
87 Satokawa H, Yokoyama H, Takase S, Wakamatsu H. Anticoagulant Therapy for Venous ThromboembolismCharacteristics of Direct Factor Xa Inhibitors. Jpn J Phlebol 2022;33:7-14. [DOI: 10.7134/phlebol.21-31] [Reference Citation Analysis]
88 De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, Giannoukas A, Gohel M, de Graaf R, Hamel-Desnos C, Jawien A, Jaworucka-Kaczorowska A, Lattimer CR, Mosti G, Noppeney T, van Rijn MJ, Stansby G, Esvs Guidelines Committee, Kolh P, Bastos Goncalves F, Chakfé N, Coscas R, de Borst GJ, Dias NV, Hinchliffe RJ, Koncar IB, Lindholt JS, Trimarchi S, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, Björck M, Labropoulos N, Lurie F, Mansilha A, Nyamekye IK, Ramirez Ortega M, Ulloa JH, Urbanek T, van Rij AM, Vuylsteke ME. Editor's Choice - European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg 2022;63:184-267. [PMID: 35027279 DOI: 10.1016/j.ejvs.2021.12.024] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 54.0] [Reference Citation Analysis]
89 Pham A, Heib A, Goodman E, Cotto R, Jafari P, Lipsitz E, Indes J. Warfarin Versus Direct Oral Anticoagulants For Patients Needing Treatment For Distal Deep Vein Thrombosis. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2022. [DOI: 10.1016/j.jvsv.2022.01.006] [Reference Citation Analysis]
90 Prandoni P, Pesavento R, Bilora F, Fernández Reyes JL, Madridano O, Soler S, Monreal M. No difference in outcome between therapeutic and preventive anticoagulation in patients with superficial vein thrombosis involving the saphenous–femoral junction. Vasc Med. [DOI: 10.1177/1358863x211066962] [Reference Citation Analysis]
91 Yavelov IS, Kaperiz KA, Drapkina OM. Anticoagulants in the treatment of superficial vein thrombosis of lower limbs: possibilities and limitations. Aterotromboz 2022;11:94-102. [DOI: 10.21518/2307-1109-2021-11-2-94-102] [Reference Citation Analysis]
92 Dong Y, He S, Li X, Zhou Z. Prevention of nNon-Vitamin K Oral Anticoagulants-Related Gastrointestinal Bleeding With Acid Suppressants: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost 2022;28:10760296211064897. [PMID: 35037779 DOI: 10.1177/10760296211064897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Petersen EL, Goßling A, Adam G, Aepfelbacher M, Behrendt CA, Cavus E, Cheng B, Fischer N, Gallinat J, Kühn S, Gerloff C, Koch-Gromus U, Härter M, Hanning U, Huber TB, Kluge S, Knobloch JK, Kuta P, Schmidt-Lauber C, Lütgehetmann M, Magnussen C, Mayer C, Muellerleile K, Münch J, Nägele FL, Petersen M, Renné T, Riedl KA, Rimmele DL, Schäfer I, Schulz H, Tahir E, Waschki B, Wenzel JP, Zeller T, Ziegler A, Thomalla G, Twerenbold R, Blankenberg S. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme. Eur Heart J 2022:ehab914. [PMID: 34999762 DOI: 10.1093/eurheartj/ehab914] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 35.0] [Reference Citation Analysis]
94 Dick F, Björck M. EJVES - a Look Ahead. Eur J Vasc Endovasc Surg 2022;63:1-2. [PMID: 35067357 DOI: 10.1016/j.ejvs.2022.01.001] [Reference Citation Analysis]
95 Rossi FH. Trombectomia em caso grave de trombose venosa iliofemoral afetando a veia femoral profunda pela técnica de punção e sessão única realizada pela veia jugular: relato de caso e descrição da técnica. J vasc bras 2022;21:e20210192. [DOI: 10.1590/1677-5449.202101921] [Reference Citation Analysis]
96 Espinola-klein C, Storck M. Venenthrombose und Lungenembolie. Chirurgie Basisweiterbildung 2022. [DOI: 10.1007/978-3-662-63366-3_59] [Reference Citation Analysis]
97 Liu L, Zhou J, Zhang Y, Lu J, Gan Z, Ye Q, Wu C, Xu G. A Nomogram for Individualized Prediction of Calf Muscular Vein Thrombosis in Stroke Patients During Rehabilitation: A Retrospective Study. Clin Appl Thromb Hemost 2022;28:10760296221117991. [PMID: 35942697 DOI: 10.1177/10760296221117991] [Reference Citation Analysis]
98 Badesha AS, Siddiqui MM, Bains BRS, Bains PRS, Khan T. A systematic review on the incidence of stent migration in the treatment of acute and chronic iliofemoral disease using dedicated venous stents. Annals of Vascular Surgery 2022. [DOI: 10.1016/j.avsg.2021.12.084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Ashrafi M, Ahmad SB, Antoniou SA, Khan T, Antoniou GA. Treatment Strategies for Proximal Deep Vein Thrombosis: A Network Meta-analysis of Randomised Controlled Trials. European Journal of Vascular and Endovascular Surgery 2022. [DOI: 10.1016/j.ejvs.2021.10.058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Geier B. Thrombose in der Intensivmedizin. Die Intensivmedizin 2022. [DOI: 10.1007/978-3-642-54675-4_67-2] [Reference Citation Analysis]
101 Rossi FH. Thrombectomy in a severe case of iliofemoral venous thrombosis involving the deep femoral vein via a single percutaneous access from the jugular vein: case report and description of the technique. J vasc bras 2022;21:e20210192. [DOI: 10.1590/1677-5449.202101922] [Reference Citation Analysis]
102 Lee M, Sa YK, Park M. Case 1: A 44-Year-Old Woman Presented With Unexplained Painful Left Leg Swelling. J Korean Med Sci 2022;37:e194. [DOI: 10.3346/jkms.2022.37.e194] [Reference Citation Analysis]
103 Chen J, Lv M, Wu S, Jiang S, Xu W, Qian J, Chen M, Fang Z, Zeng Z, Zhang J. Severe Bleeding Risks of Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism: A Network Meta-Analysis of Randomised Controlled Trials. Eur J Vasc Endovasc Surg 2021:S1078-5884(21)00882-0. [PMID: 34973879 DOI: 10.1016/j.ejvs.2021.10.054] [Reference Citation Analysis]
104 Nana P, Avgerinos E, Spanos K, Giannoukas A, Labropoulos N. Gaps arising from randomized controlled trials on thrombolysis for proximal deep vein thrombosis of the lower limb. J Vasc Surg Venous Lymphat Disord 2022;10:196-199.e2. [PMID: 34920845 DOI: 10.1016/j.jvsv.2021.07.020] [Reference Citation Analysis]
105 Budak AB, Gunertem OE, Ozisik K, Gunaydin S. Pharmacomechanical catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis in a large study population. J Vasc Surg Venous Lymphat Disord 2021:S2213-333X(21)00593-X. [PMID: 34890845 DOI: 10.1016/j.jvsv.2021.11.005] [Reference Citation Analysis]
106 Rass K, Gerontopoulou SA, Wienert V. Oberflächliche Venenthrombose der Beinvenen – Eine systematische Übersicht – Teil 1: Definition, Ätiologie, Diagnostik. Phlebologie 2021;50:364-375. [DOI: 10.1055/a-1238-6613] [Reference Citation Analysis]
107 Palareti G, Bignamini AA, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V. Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study. Clin Appl Thromb Hemost 2021;27:10760296211049402. [PMID: 34841907 DOI: 10.1177/10760296211049402] [Reference Citation Analysis]
108 Gunawardena T. Direct oral anticoagulants: A review for the non-specialist. Hematol Rep 2021;13:9239. [PMID: 35003572 DOI: 10.4081/hr.2021.9239] [Reference Citation Analysis]
109 Chen XT, Zhang Q, Zhou CQ, Han YF, Cao QQ. Anticoagulant treatment for pulmonary embolism in patient with cerebral hemorrhage secondary to mechanical thrombectomy: A case report. World J Clin Cases 2021; 9(33): 10279-10285 [PMID: 34904100 DOI: 10.12998/wjcc.v9.i33.10279] [Reference Citation Analysis]
110 Sun KX, Cui B, Cao SS, Huang QX, Xia RY, Wang WJ, Wang JW, Yu F, Ding Y. Cost-Effectiveness Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Venous Thromboembolism in China. Front Pharmacol 2021;12:716224. [PMID: 34744710 DOI: 10.3389/fphar.2021.716224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
111 Hou J, Wang W, Cai H, Chen J, Chen B, Shen Z, Tang Y, Li J, Liu S, Mei Y, Wang J, Lu S. Patients with right lower extremity deep vein thrombosis have a higher risk of symptomatic pulmonary embolism: a retrospective study of 1585 patients. Ann Vasc Surg 2021:S0890-5096(21)00787-1. [PMID: 34748950 DOI: 10.1016/j.avsg.2021.08.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Heller T, Becher M, Kröger JC, Beller E, Heller S, Höft R, Weber MA, Meinel FG. Isolated calf deep venous thrombosis: frequency on venous ultrasound and clinical characteristics. BMC Emerg Med 2021;21:126. [PMID: 34717549 DOI: 10.1186/s12873-021-00516-1] [Reference Citation Analysis]
113 Kürşat Bozkurt A, Tankut Akay H, Tanzer Çalkavur İ, Şırlak M, Onur Balkanay O, Uğuz E, Doğancı S, Polat A, Bayrak S, Bozok Ş, Barış Durukan A, Erdil N, Erer D, Şenay Ş, Utku Ünal E, Yavaş S. National guidelines on the management of venous thromboembolism: Joint guideline of the Turkish Society of Cardiovascular Surgery, National Society of Vascular and Endovascular Surgery, and Phlebology Society. Turk Gogus Kalp Dama 2021;29:562-576. [DOI: 10.5606/tgkdc.dergisi.2021.22121] [Reference Citation Analysis]
114 Králík R. (Thrombosis of temporary caval filter in a patient with subacute heparin-induced thrombocytopenia). Cor Vasa 2021;63:603-7. [DOI: 10.33678/cor.2021.056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Chan NC, Weitz JI. Ciraparantag as a potential universal anticoagulant reversal agent. Eur Heart J 2021:ehab706. [PMID: 34648621 DOI: 10.1093/eurheartj/ehab706] [Reference Citation Analysis]
116 Du J, Nie M, Yan Z, Fu J, Sun J, Liu F. Safety and Efficacy of Rivaroxaban for Inferior Vena Cava Thrombosis after Successful Catheter-Directed Thrombolysis. Semin Thromb Hemost 2021. [PMID: 34624911 DOI: 10.1055/s-0041-1733924] [Reference Citation Analysis]
117 Goldhaber SZ, Magnuson EA, Chinnakondepalli KM, Cohen DJ, Vedantham S. Catheter-directed thrombolysis for deep vein thrombosis: 2021 update. Vasc Med 2021;26:662-9. [PMID: 34606385 DOI: 10.1177/1358863X211042930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Badesha AS, Tamber KK, Powezka K, Hodge S, Khan T. Management of Acute Iliofemoral Deep Venous Thrombosis in Inflammatory Bowel Disease - Transitioning From Conservative Management to Early Intervention. Cureus 2021;13:e17426. [PMID: 34589335 DOI: 10.7759/cureus.17426] [Reference Citation Analysis]
119 Bauersachs RM. [Superficial Vein Thrombosis]. Dtsch Med Wochenschr 2021;146:1237-42. [PMID: 34553346 DOI: 10.1055/a-1286-2153] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Debus ES, Earnshaw J, Venermo M, Björck M. Virtual Vascular: Gathering Pace. Eur J Vasc Endovasc Surg 2021;62:509-10. [PMID: 34531118 DOI: 10.1016/j.ejvs.2021.07.006] [Reference Citation Analysis]
121 Bikdeli B, Hogan H, Morrison RB, Fanikos J, Campia U, Barns BM, Pfeferman MB, Snyder JE, Khairani CD, Goldhaber SZ, Piazza G. Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO Trial. Thromb Haemost 2021. [PMID: 34530470 DOI: 10.1055/a-1646-2244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Nana P, Dakis K, Peroulis M, Rousas N, Spanos K, Kouvelos G, Arnaoutoglou E, Matsagkas M. The Role of Direct Oral Anticoagulants in Cancer-Associated Thrombosis According to the Current Literature. Medicina (Kaunas) 2021;57:960. [PMID: 34577883 DOI: 10.3390/medicina57090960] [Reference Citation Analysis]
123 Wik HS, Kahn SR, Eriksson H, Morrison D, Ghanima W, Schulman S, Sandset PM. Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients. J Thromb Haemost 2021. [PMID: 34255420 DOI: 10.1111/jth.15449] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
124 Gunawardena T, Godakandage M, Abeywickrama S, Cassim R, Wijeyaratne M. Spontaneous Transection of the Superficial Femoral Artery with Devastating Outcomes: A Case Report. Vasc Specialist Int 2021;37:22. [PMID: 34248054 DOI: 10.5758/vsi.210032] [Reference Citation Analysis]
125 He X, Zhang L, Qiu H, Jiang X, Zhang F, Peng J, Zhang H, Yu W, Gao X, Dong R, Zhao Z. Two New Methods of Supine Venographically Guided Popliteal Vein Puncture: A Retrospective Study. Eur J Vasc Endovasc Surg 2021:S1078-5884(21)00426-3. [PMID: 34244092 DOI: 10.1016/j.ejvs.2021.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Quintas A, Bastos Gonçalves F. INSIGHTS into Superficial Vein Thrombosis Management - Some New Light and Room for Improvement. Eur J Vasc Endovasc Surg 2021;62:250. [PMID: 34217599 DOI: 10.1016/j.ejvs.2021.05.008] [Reference Citation Analysis]
127 Qanadli SD, Rotzinger D. Is Management of Major Bleeding in Patients Taking Anticoagulants Restricted to Reversal Strategies? European Journal of Vascular and Endovascular Surgery 2021;62:142. [DOI: 10.1016/j.ejvs.2021.03.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Bauersachs R, Gerlach HE, Heinken A, Hoffmann U, Langer F, Noppeney T, Pittrow D, Klotsche J, Rabe E. Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT). Eur J Vasc Endovasc Surg 2021;62:241-9. [PMID: 34210599 DOI: 10.1016/j.ejvs.2021.04.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
129 Faggioli G, Pini R. New Routes for Continuous Endovascular Advancement. Eur J Vasc Endovasc Surg 2021:S1078-5884(21)00371-3. [PMID: 34108125 DOI: 10.1016/j.ejvs.2021.04.026] [Reference Citation Analysis]
130 Wienert V, Gerontopoulou SA, Rass K. Oberflächliche Venenthrombose der Beinvenen – Eine systematische Übersicht – Teil 2: Therapie. Phlebologie 2022;51:10-20. [DOI: 10.1055/a-1238-6645] [Reference Citation Analysis]
131 Karathanos C, Nana P, Spanos K, Kouvelos G, Brotis A, Matsagas M, Giannoukas A. Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: a systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord 2021:S2213-333X(21)00212-2. [PMID: 33965611 DOI: 10.1016/j.jvsv.2021.04.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
132 Kakkos SK, Gohel M, Bauersachs R. Re "Is Management of Major Bleeding in Patients Taking Anticoagulants Restricted to Reversal Strategies?". Eur J Vasc Endovasc Surg 2021;62:142-3. [PMID: 33966985 DOI: 10.1016/j.ejvs.2021.03.030] [Reference Citation Analysis]
133 Langer S, Regeniter P. Interventionelle Therapie der akuten iliofemoralen Thrombose. Phlebologie 2021;50:208-14. [DOI: 10.1055/a-1424-4820] [Reference Citation Analysis]
134 Mühlberger D, Falkenstein T, Mumme A, Stücker M, Reich-schupke S, Hummel T. Stellenwert der operativen multimodalen venösen Thrombektomie bei der Behandlung der akuten iliofemoralen Thrombose. Phlebologie 2021;50:196-201. [DOI: 10.1055/a-1424-8388] [Reference Citation Analysis]
135 Thapar A, Lawton R, Burgess L, Shalhoub J, Bradbury A, Cullum N, Epstein D, Gohel M, Horne R, Hunt BJ, Norrie J, Davies AH. Compression hosiery to avoid post-thrombotic syndrome (CHAPS) protocol for a randomised controlled trial (ISRCTN73041168). BMJ Open 2021;11:e044285. [PMID: 33846151 DOI: 10.1136/bmjopen-2020-044285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
136 Gloviczki P. Evidence Supports Early Thrombus Removal in Iliofemoral Venous Thrombosis. Eur J Vasc Endovasc Surg 2021;61:179-80. [PMID: 33436303 DOI: 10.1016/j.ejvs.2020.12.023] [Reference Citation Analysis]
137 Chechulova A, Tomchenko A, Nokhrin S, Soroka V, Khomchuk I. Bleeding in elderly and senile patients with deep vein thrombosis on anticoagulant therapy. Flebol 2021;15:170. [DOI: 10.17116/flebo202115031170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Zabolotskikh IB, Kirov M, Afonchikov V, Bulanov A, Grigoryev E, Grigoryev S, Gritsan A, Zamyatin M, Kurapeev I, Lebedinskii K, Lomivorotov V, Lubnin A, Ovechkin A, Potievskaya V, Roitman E, Sinkov S, Subbotin V, Shadrin R, Shulutko E. Perioperative management of patients receiving long-term antithrombotic therapy. Clinical practice recommendations of the national “Federation of Anesthesiologists and Reanimatologists”. Annals of critical care 2021. [DOI: 10.21320/1818-474x-2021-3-7-26] [Reference Citation Analysis]
139 Lozano Sánchez FS, Velasco Hernández P, Zarco Castillo J, Salvador Calvo R. Direct oral anticoagulants in the treatment of venous thromboembolic disease associated with cancer. Evidence and recommendations. Angiologia 2021. [DOI: 10.20960/angiologia.00313] [Reference Citation Analysis]